Center to Evaluate "Real World" Risks and Benefits of Medical Treatment
The Johns Hopkins Bloomberg School of Public Health was selected to join a newly established network of 13 research centers organized to evaluate how medications and treatments perform in the real world.
As part of the new initiative known as Developing Evidence to Inform Decisions about Effectiveness (or DEcIDE), the Hopkins center will begin working on a study to evaluate the effectiveness of a new treatment for diabetes, inhaled insulin. The DEcIDE network was established by the Agency for Healthcare Research and Quality (AHRQ) as part of a $15 million program to improve health services and therapies under the Medicare Prescription Drug, Improvement and Modernization Act. The DEcIDE network is designed to produce rapid answers to targeted questions, with results that will be translated quickly into practice. Click here for more information.